logo

Shariatga muvofiqlik sharhi

Halol

Acadia Pharmaceuticals Inc. (ACAD) hozirda Akinda shariat skriningi (AAOIFI) bo'yicha Halol deb tasniflanadi.

Acadia Pharmaceuticals Inc. haqida

Acadia Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders.

Acadia Pharmaceuticals Inc. (ACAD) Healthcare sektorida, Biotechnology sohasida faoliyat yuritadi.

Nega halol: aksiya AAOIFI ning uchala tekshiruvidan o'tadi. Nomuvofiq daromad — 2.88% (chegara 5%), foizli qarz — 0.33% (chegara 30%), foizli qimmatli qog'ozlar va aktivlar — 23.14% (chegara 30%).

Agar sizda ACAD aksiyasi bo'lsa, daromadning nomuvofiq qismini poklash uchun olgan dividendlaringizning 2.88% qismini xayriyaga bering.

Kompaniya faoliyati
2.88%Chegara 5%Muvaffaq
Foizli qarz
0.33%Chegara 30%Muvaffaq
Foizli qimmatli qog‘ozlar va aktivlar
23.14%Chegara 30%Muvaffaq
Dividendlarni poklash
2.88%Xayriyaga beriladigan dividend ulushiPoklash kalkulyatori

Oxirgi yangilanish: 22-okt, 2026 · Skrining ma'lumot uchun; bu fatvo emas. Shaxsiy maslahat uchun malakali olim bilan maslahatlashing.

Kontentni ko'rish uchun tizimga kiring

Asosiy ko'rsatkichlar

Kontentni ko'rish uchun tizimga kiring

Kontentni ko'rish uchun tizimga kiring

Kompaniya profili

Kontentni ko'rish uchun tizimga kiring

Tez-tez beriladigan savollar

Acadia Pharmaceuticals Inc. (ACAD) bo‘yicha qisqa javoblar. Akinda skrining yorlig‘i: Halol.